VN January 2026

Vetnews | Januarie 2026 6 « BACK TO CONTENTS A raw deal: the intersection of the immunocompromised cat, influenza, and a lapse of infection prevention and control measures Kelli J. Maddock1 https://doi.org/10.1128/ asmcr.00134-25. ABSTRACT The case report by Chen et al. (ASM Case Rep 1:e00134-25, 2025, https:// doi.org/10.1128/asmcr.00134-25) importantly describes nosocomial transmission of s in an immunocompromised resident clinic cat. This case highlights several significant public health threats, starting with HPAI spillover from birds to cats, foxes, and cattle; probable HPAI infection due to contaminated commercially prepared raw pet foods; nosocomial infection of an immunocompromised animal; and lapses in infection prevention and control (IPC) measures. This case underscores the need for formal IPC guidelines or a risk assessment-based protocol for resident clinic or personal pets in veterinary settings. As the availability of and interest in using commercial raw pet foods increase, there is a need for education surrounding infectious disease risk, safe handling, and handwashing procedures for use of these products, as well as the potential risk for faecal shedding of important enteric pathogens. Further emphasising the importance of IPC, nosocomial outbreaks caused by Salmonella and antimicrobial-resistant bacteria have been identified in large animal and companion animal practices, with a recent case describing probable zoonotic and nosocomial spread of carbapenem-resistant organisms. To mitigate these risks, veterinary practices (clinics or hospitals) require resources and education for IPC to minimise and investigate nosocomial transmission of infectious diseases. Finally, the availability of highquality point-of-care test options for veterinary infectious diseases would support human, animal, and population health by providing rapid and actionable results for disease response. The case report by Chen et al. (1) describes a nosocomial infection of highly pathogenic avian influenza (HPAI) H5N1 in an immunocompromised domestic cat. The cat was a resident of the clinic and had contact with clinic spaces and personnel who had previous contact with another cat experiencing respiratory illness after consumption of recalled (2), potentially HPAI-contaminated raw cat food. This case represents an interesting intersection of an immunocompromised resident of a veterinary clinic and several public health phenomena of our time, namely, the spillover of HPAI from birds to cats, foxes, and cattle; the raw pet food diet trend; and an increasing need for infection prevention and control (IPC) measures in veterinary practices (clinics or hospitals). Beyond these factors, human, animal, and population health, and potentially antimicrobial stewardship, could be supported by increased availability of high-quality infectious disease point-of-care testing (POCT) in veterinary practices. It is not uncommon for veterinary practices to adopt resident clinic pets with difficult-to-manage conditions that may be too challenging or expensive for the average pet owner to navigate. While surrounding these animals with veterinary professionals and providing care is altruistic, paradoxically, they are also residing in an environment where they may be at a high risk of contracting a debilitating or lethal illness from other patients. While no formal IPC guidance or policy currently exists for personal or clinic-residing pets, there is a significant biosecurity risk and the potential for infectious disease spread for these animals, particularly if they are also immunocompromised. In 2019, the American Society for Microbiology drafted formal guidance for service animals in teaching laboratory settings (3), with emphasis placed on protecting both the animal and people in the space from physical harm (trips and uncontrolled animals), biohazards, and biosecurity risks. Veterinary practices should evaluate potential risks to these resident clinic pets and whether procedural control or physical segregation from common areas that may be contaminated by other patients is sufficient to protect these vulnerable animals. In recent years, a trend toward providing raw pet food for perceived nutrition benefits (4–6) has become a more mainstream dietary option for pets, with multiple commercial vendors offering raw products marketed to pet owners. Despite numerous infectious disease events (7) and decades of evidence to the contrary (8), raw milk is also experiencing a new era of public perception as a nutritious, safe, and natural alternative to pasteurised dairy products for people and pets alike. Commercial raw pet foods have also been the subject of product recalls (2, 9, 10) due to potential HPAI contamination, and both raw pet foods and raw milk have been linked to HPAI infection in companion animals, including the probable source of HPAI in this case (1). While the risk of cat-to-human transmission of HPAI is currently low, raw diets introduce additional risks to pets and their owners. These products are often contaminated with ever-present gastrointestinal nemesis, Salmonella, Listeria monocytogenes, Campylobacter, and diarrheagenic Escherichia coli (4, 5, 11–13), with a recent outbreak involving raw pet food and a multidrug-resistant strain of Salmonella I 4, [5], 12:i:- (14). Pet owners may not realise that these raw commercial products require strict handling, just like human-grade meat products that are typically cooked. They also may be unaware of the risks associated with these raw products. Beyond product handling risk, there is an increased risk of faecal Salmonella shedding from pets who have consumed contaminated products (15, 16), increasing the risk of illness for pet owners or environmental contamination.

RkJQdWJsaXNoZXIy OTc5MDU=